[go: up one dir, main page]

AU2002336982A1 - C2-disubstituted Indane-1-ol systems, method for their production and their use as medicaments - Google Patents

C2-disubstituted Indane-1-ol systems, method for their production and their use as medicaments

Info

Publication number
AU2002336982A1
AU2002336982A1 AU2002336982A AU2002336982A AU2002336982A1 AU 2002336982 A1 AU2002336982 A1 AU 2002336982A1 AU 2002336982 A AU2002336982 A AU 2002336982A AU 2002336982 A AU2002336982 A AU 2002336982A AU 2002336982 A1 AU2002336982 A1 AU 2002336982A1
Authority
AU
Australia
Prior art keywords
medicaments
systems
production
indane
disubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002336982A
Other versions
AU2002336982B2 (en
Inventor
Martin Bickel
Matthias Gossel
Gerhard Jaehne
Volker Krone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10142663A external-priority patent/DE10142663B4/en
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Publication of AU2002336982A1 publication Critical patent/AU2002336982A1/en
Assigned to SANOFI-AVENTIS DEUTSCHLAND GMBH reassignment SANOFI-AVENTIS DEUTSCHLAND GMBH Request for Assignment Assignors: AVENTIS PHARMA DEUTSCHLAND GMBH
Application granted granted Critical
Publication of AU2002336982B2 publication Critical patent/AU2002336982B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002336982A 2001-08-31 2002-08-17 C2-disubstituted Indane-1-ol systems, method for their production and their use as medicaments Ceased AU2002336982B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10142663A DE10142663B4 (en) 2001-08-31 2001-08-31 C2-Disubstituted indan-1-ol systems
DE10142663.1 2001-08-31
PCT/EP2002/009203 WO2003020695A1 (en) 2001-08-31 2002-08-17 C2-disubstituted indane-1-ol systems, method for their production and their use as medicaments

Publications (2)

Publication Number Publication Date
AU2002336982A1 true AU2002336982A1 (en) 2003-06-05
AU2002336982B2 AU2002336982B2 (en) 2008-01-31

Family

ID=7697234

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002336982A Ceased AU2002336982B2 (en) 2001-08-31 2002-08-17 C2-disubstituted Indane-1-ol systems, method for their production and their use as medicaments

Country Status (11)

Country Link
US (1) US6982353B2 (en)
EP (1) EP1425264B1 (en)
JP (1) JP4250078B2 (en)
AT (1) ATE412630T1 (en)
AU (1) AU2002336982B2 (en)
CA (1) CA2458523A1 (en)
DE (2) DE10142663B4 (en)
IL (1) IL160603A0 (en)
MX (1) MXPA04001849A (en)
PE (1) PE20030362A1 (en)
WO (1) WO2003020695A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10142663B4 (en) 2001-08-31 2004-08-19 Aventis Pharma Deutschland Gmbh C2-Disubstituted indan-1-ol systems
EP1849465A4 (en) * 2005-02-18 2008-12-24 Takeda Pharmaceutical AGENT FOR CONTROLLING THE FUNCTION OF THE GPR34 RECEPTOR

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3050564A (en) 1958-12-02 1962-08-21 Exxon Research Engineering Co Preparation of new hydroperoxides by the cooxidation of olefinic compounds and mercaptans
US3016349A (en) 1959-08-10 1962-01-09 Exxon Research Engineering Co Denitrogenation of petroleum
US3043824A (en) 1959-09-28 1962-07-10 Exxon Research Engineering Co Hydroperoxide and sulfoxide compounds
US3016348A (en) 1959-11-02 1962-01-09 Universal Oil Prod Co Manufacture and use of sulfided hydrocarbon purification catalyst
YU33726B (en) 1969-07-04 1978-02-28 Montedison Spa Process for cross-linking of plastomers
US5808062A (en) 1993-11-19 1998-09-15 Warner-Lambert Company Pyrone derivatives as protease inhibitors and antiviral agents
PT729465E (en) 1993-11-19 2003-06-30 Parke Davis & Co PIRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS
US5622514A (en) 1995-06-30 1997-04-22 The Whitaker Corporation Coverless pin grid array socket
DE69629387T2 (en) * 1995-12-06 2004-06-24 Venantius Ltd. DIMERE INDAN COMPOUNDS AND THEIR PHARMACEUTICAL USE
EP1826216A1 (en) 1996-08-30 2007-08-29 Novo Nordisk A/S Glp-1 derivatives
US5985913A (en) 1996-11-29 1999-11-16 Osi Pharmaceuticals, Inc. Tetracyclic compounds for enhancing biosynthesis of erythropoietin, compositions containing same, and methods of use thereof
ATE246190T1 (en) 1996-12-31 2003-08-15 Reddys Lab Ltd Dr HETEROCYCLIC COMPOUNDS, METHODS FOR THE PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND THEIR USE IN THE TREATMENT OF DIABETIS AND RELATED DISEASES
EP0986530A1 (en) 1997-06-05 2000-03-22 Venantius Limited Indane compounds and their pharmaceutical use
BR9810592A (en) 1997-07-16 2000-09-12 Novo Nordisk As Compound, processes for preparing a compound, for treating or preventing diseases of the endocrine system and for the manufacture of a drug, pharmaceutical composition, and, use of a compound
DE19844547C2 (en) * 1998-09-29 2002-11-07 Aventis Pharma Gmbh Polycyclic dihydrothiazoles, process for their preparation and their use as medicines
DE19908533A1 (en) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclic thiazole systems, processes for their preparation and medicaments containing these compounds
EP1078632A1 (en) 1999-08-16 2001-02-28 Sanofi-Synthelabo Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
DE10142660A1 (en) 2001-08-31 2003-03-20 Aventis Pharma Gmbh Use of derivatives of C2-substituted indan-1-ol systems for the preparation of medicaments for the prophylaxis or treatment of obesity
DE10142662B4 (en) 2001-08-31 2004-07-08 Aventis Pharma Deutschland Gmbh Derivatives of C2-substituted indan-1-ol systems and their use as pharmaceuticals
DE10142667B4 (en) 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh C2-substituted indan-1-oles and their derivatives and their use as medicines
DE10142663B4 (en) 2001-08-31 2004-08-19 Aventis Pharma Deutschland Gmbh C2-Disubstituted indan-1-ol systems
DE10142666A1 (en) 2001-08-31 2003-03-20 Aventis Pharma Gmbh Use of C2-substituted indan-1-ol systems for the preparation of medicaments for the prophylaxis or treatment of obesity
DE10142661B4 (en) 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh Poly-substituted indan-1-ol systems and their use as pharmaceuticals
DE10142659A1 (en) 2001-08-31 2003-03-20 Aventis Pharma Gmbh Use of multiply substituted indan-1-ol. Systems for the preparation of medicaments for the prophylaxis or treatment of obesity

Similar Documents

Publication Publication Date Title
AU2002337047A1 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
AU2003282094A1 (en) Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments
IL160440A (en) Dihydropteridinones, method for producing the same and the use thereof as medicaments
AU2003257465A1 (en) Substituted diaryl heterocycles, method for the production and use thereof as medicaments
AU2002344151A1 (en) Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
AU2002213977A1 (en) Novel anticholinergics, method for the production thereof and use thereof as medicaments
AU2002219174A1 (en) Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof
AU2002310741A1 (en) Superabsorber, method for the production and use thereof
AU2002250858A1 (en) Capsule-in-capsule system and method for the production thereof
PL376399A1 (en) Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
IL162316A0 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t
AU2003276262A1 (en) Laminated system, coating composition and method for the production thereof
AU2002318742A1 (en) Pullulan-containing powder, process for producing the same and use thereof
AU2003303735A1 (en) Oligomer silasesquioxanes, method for the production thereof, and use of the same
AU2002333448A1 (en) Derivatives of C2-substituted indan-1-ol systems, methods for the production thereof and their use as medicaments
AU2003246840A1 (en) Anti-hiv composition, production method thereof and medicament
AU2002348998A1 (en) N-methyl-homocystines, use thereof and method for the production thereof
AU2002336982A1 (en) C2-disubstituted Indane-1-ol systems, method for their production and their use as medicaments
AU2002333449A1 (en) C2-substituted indane-1-ols and their derivatives, method for their production and their use as medicaments
AU2002339519A1 (en) Coniosulphides and their derivatives, method for their production and use as medicaments
AU2002336085A1 (en) C2-substituted Indane-1-ones and their derivatives, method for their production and their use as medicaments
AU2002336983A1 (en) C2-disubstituted Indane-1-ones and their derivatives, method for their production and their use as medicaments
AU2002256705A1 (en) Corrosion-stable laminate, method for the production thereof, and its use
AU1021001A (en) Cyclic biphenyls, method for the production thereof, and their use as medicaments
AU7517800A (en) 3-vinylpyrrole derivatives, method for the production thereof and their use as medicaments